I agree that this site is using cookies. You can find further informations here.
X
Elassaiss-Schaap, J
19  results:
Search for persons X
?
1

Multivariate pharmacokinetic/pharmacodynamic (PKPD) analysi..:

van den Brink, W.J. ; Elassaiss-Schaap, J. ; Gonzalez-Amoros, B....
European Journal of Pharmaceutical Sciences.  109 (2017)  - p. 431-440 , 2017
Link: https://doi.org/10.1016/..
 
?
2

Using Model-Based "Learn and Confirm" to Reveal the Pharmac..:

Elassaiss-Schaap, J ; Rossenu, S ; Lindauer, A...
CPT: Pharmacometrics & Systems Pharmacology.  6 (2016)  1 - p. 21-28 , 2016
Link: https://doi.org/10.1002/..
 
?
3

Pembrolizumab: Role of Modeling and Simulation in Bringing ..:

de Greef, R ; Elassaiss-Schaap, J ; Chatterjee, M...
CPT: Pharmacometrics & Systems Pharmacology.  6 (2016)  1 - p. 5-7 , 2016
Link: https://doi.org/10.1002/..
 
?
4

Model-Based Characterization of the Pharmacokinetics of Pem..:

Ahamadi, M ; Freshwater, T ; Prohn, M...
CPT: Pharmacometrics & Systems Pharmacology.  6 (2016)  1 - p. 49-57 , 2016
Link: https://doi.org/10.1002/..
 
?
5

Population Pharmacokinetic/Pharmacodynamic Modeling of Tumo..:

Chatterjee, MS ; Elassaiss-Schaap, J ; Lindauer, A...
CPT: Pharmacometrics & Systems Pharmacology.  6 (2016)  1 - p. 29-39 , 2016
Link: https://doi.org/10.1002/..
 
?
6

Translational Pharmacokinetic/Pharmacodynamic Modeling of T..:

Lindauer, A ; Valiathan, CR ; Mehta, K...
CPT: Pharmacometrics & Systems Pharmacology.  6 (2016)  1 - p. 11-20 , 2016
Link: https://doi.org/10.1002/..
 
?
7

3344 Relationship between pembrolizumab exposure and effica..:

Kang, S.P. ; Chatterjee, M. ; Ahamadi, M....
European Journal of Cancer.  51 (2015)  - p. S682 , 2015
Link: https://doi.org/10.1016/..
 
?
8

A pharmacological tool to assess vasopressinergic co-activa..:

Jacobs, GE ; van Gerven, JMA ; de Kam, ML...
Journal of Psychopharmacology.  25 (2010)  3 - p. 361-369 , 2010
Link: https://doi.org/10.1177/..
 
?
9

Desmopressin as a pharmacological tool in vasopressinergic ..:

Jacobs, GE ; Hulskotte, EGJ ; van Gerven, JMA...
Journal of Psychopharmacology.  25 (2010)  3 - p. 353-360 , 2010
Link: https://doi.org/10.1177/..
 
?
10

An asymptotic description of a basic FcRn-regulated clearan..:

Kátai, Csaba B. ; Smithline, Shepard J. ; Thalhauser, Craig J...
Journal of Pharmacokinetics and Pharmacodynamics.  , 2024
Link: https://doi.org/10.1007/..
 
?
11

Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokineti..:

Saleh, Mohammed A. A. ; Gülave, Berfin ; Campagne, Olivia...
Pharmaceutical Research.  40 (2023)  11 - p. 2555-2566 , 2023
Link: https://doi.org/10.1007/..
 
?
12

The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but ..:

Saleh, Mohammed A.A. ; Hirasawa, Makoto ; Sun, Ming...
European Journal of Pharmaceutical Sciences.  181 (2023)  - p. 106345 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Drug Distribution in Brain and Cerebrospinal Fluids in Rela..:

Saleh, Mohammed A. A. ; Bloemberg, Julia S. ; Elassaiss-Schaap, Jeroen.
Pharmaceutical Research.  39 (2022)  7 - p. 1303-1319 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Lumbar cerebrospinal fluid-to-brain extracellular fluid sur..:

Saleh, Mohammed A. A. ; Loo, Chi Fong ; Elassaiss-Schaap, Jeroen.
Journal of Pharmacokinetics and Pharmacodynamics.  48 (2021)  5 - p. 725-741 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokineti..:

Saleh, Mohammed A. A ; Gülave, Berfin ; Campagne, Olivia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10733198/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15